The surgeons at Temple University Hospital performed the first heart transplant in the Delaware Valley in 1984 and the first heart-lung transplant in 1987. Now nearing its 1,000th heart transplant, Temple maintains its role as a leader in transplantation while continuing to advance the treatment of end-stage heart failure with innovative therapies and an aggressive, multi-disciplinary approach derived from decades of experience.
Having managed countless complex cases of advanced heart failure, Temple University Hospital takes pride in the myriad treatments it offers. The Section of Cardiology's ultimate goal is to exhaust every possible option before turning to transplant. Our physicians use drug therapies that include novel, investigative medicines and interventional therapies including biventricular pacing with monitoring capabilities to maximize the function of the patient in the safest and least invasive way. When patients no longer respond to medical therapy, experienced cardiothoracic surgeons provide the appropriate surgical intervention, from valve repair and replacement to high-risk bypass surgery, ventricular assist therapy or cardiac transplantation.
The Section of Cardiology is currently involved in multiple clinical trials focused on long-term research in patients with end-stage organ dysfunction and ventricular assist devices (VADs) as destination therapy, as well as bridge-to-transplant therapy.
Cardiology physicians consider their relationship with the referring physician to be one of co-management and make it a priority to keep communication lines open. When a patient enters the Temple system, the referring physician receives a phone call providing contact information. The Section of Cardiology is always available by fax, phone or through a medical liaison. Referring physicians are updated at regular intervals throughout their patient's care a Temple University Hospital, and upon discharge both the physician and patient are provided with the reports and information necessary to continue successful treatment.
Faced with an aging patient population, providing a variety of therapies for end-stage heart failure is a critical mission requiring the utilization of the newest technologies and treatments.
Already a nationally recognized hospital for advanced heart failure patients, in 2003 Temple University became the first institution in Philadelphia to implant a left ventricular assist device as a destination therapy. Today, we have experience with over 200 VAD patients, and continue to treat critically ill heart failure patients with these life-saving pumps, offering patients improved quality of life whether the indication is bridge to recovery, bridge to transplant or destination therapy. We also use several home infusion protocols to allow patients to maintain a stable heart status when oral medications are no longer adequate.
At 20 years and counting, Temple has the longest running transplant program in the region. Our depth of experience is unmatched, leading to exceptional patient outcomes well above national standards.
Surgeons at Temple University Hospital perform more transplants than most national centers in addition to handling some of the country's most complicated cases. Our fully integrated cardiopulmonary transplant team performs heart-lung transplants only a few centers in the country can accommodate. With an extensive database at our fingertips, we have the ability to compare cases across a span of almost 1,000 patients transplanted since 1984.
Our team consists of a large, multidisciplinary group of over twenty specialists and subspecialists who ensure quality patient care from evaluation through the post-transplant period. Not only do patients with comorbidities have access to experts within the Temple Heart Center, but they also benefit from the expertise of specialists throughout our hospital who are experienced in the care of transplant patients and who help manage every aspect of the patient's care. We currently manage over 500 post-transplant patients, some of whom have been with us for over 15 years.
Our clinical trials, advanced surgical procedures and rehabilitation programs have made Temple University Hospital one of the country's most comprehensive centers for organ failure treatment and research.
Temple is able to offer the very latest techniques in advanced heart failure treatment including cardiac resynchronization therapy, implanted cardioverter-defibrillators, minimally invasive surgery, off-pump bypass and high-risk coronary and valvular vascularization, giving new hope for improving quality of life and symptom relief for those with end-stage heart disease.
Department of Medicine
Section of Cardiology, General Appointments
3401 North Broad Street
Suite 945, Zone C
Philadelphia, PA 19140